sábado, 26 de junio de 2010

Unlocking genetic disease with next-generation sequencing

Contact: Tamsin Milewicz
Public Library of Science

Unlocking genetic disease with next-generation sequencing
Using new, whole-genome sequencing technology coupled with classic methods of genetic investigation, scientists at Duke University, along with colleagues at Johns Hopkins, have discovered two mutations in the same gene that seem to cause metachondromatosis in humans. This is a rare, heritable disease that leads to bony growths, mostly on the hands and feet. The discovery, published June 17 in the open-access journal PLoS Genetics, was accomplished by sequencing the entire genome of just one individual from a family with multiple cases of metachodromatosis, a feat that until recently would not have been possible.

In the past, determining the genetic causes of rare heritable diseases could be time-consuming and costly, and for some cases, simply proved impossible. In the case of metachondromatosis, next-generation sequencing quickly implicated a deletion in the gene PTPN11, and tests confirmed that each individual affected with metachondromatosis in the studied family carried this mutation. The findings may also reveal the molecular basis of other diseases, like Maffucci syndrome and Ollier's disease, since individuals with those disorders have similar physical characteristics as people with metachondromatosis.

Furthermore, David Goldstein, Director of the Center for Human Genome Variation at Duke and senior author of the paper, said: "One exciting feature of the study is that similar modest linkage evidence is sometimes observed for common diseases too, suggesting that such family-based sequencing may also prove valuable for the more difficult-to-study common complex diseases."

The researchers say the next steps are to investigate the biological effects of the mutations and whether related syndromes are influenced by the same gene. These findings suggest that next-generation sequencing may allow the rapid resolution of many of the familial diseases that have so far eluded researchers, and provide encouragement for sequencing-based studies of common disease.

FINANCIAL DISCLOSURE: This study was funded by discretionary funds of the Center for Human Genome Variation at Duke University Medical School, the Kathryn and Alan Greenberg Center for Skeletal Dysplasias, the NIAID Center for HIV/AIDS Vaccine Immunology grant AI067854, and the Bill & Melinda Gates foundation grant 157412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

COMPETING INTERESTS: The authors have declared that no competing interests exist.

CITATION: Sobreira NLM, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, et al. (2010) Whole-Genome Sequencing of a Single Proband Together with Linkage Analysis Identifies a Mendelian Disease Gene. PLoS Genet 6(6): e1000991. doi:10.1371/journal.pgen.1000991

IN YOUR COVERAGE, PLEASE USE THIS LINK TO PROVIDE ACCESS TO THE FREELY AVAILABLE ARTICLE (the link will go live when the embargo ends): http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000991
Dr. David Goldstein
Phone: 919-684 0896 begin_of_the_skype_highlighting 919-684 0896 end_of_the_skype_highlighting


This press release refers to an upcoming article in PLoS Genetics. The release is provided by the article authors and their institutions. Any opinions expressed in this release or article are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.

About PLoS Genetics

PLoS Genetics (http://www.plosgenetics.org) reflects the full breadth and interdisciplinary nature of genetics and genomics research by publishing outstanding original contributions in all areas of biology.

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org.
Unlocking genetic disease with next-generation sequencing

No hay comentarios:

Publicar un comentario